Business Description
HeartFlow Inc
NAICS : 923120
SIC : 7372
ISIN : US42238D1072
Total Employee Number:
843Description
HeartFlow Inc is a commercial-stage medical technology company that provides software and artificial intelligence (AI) designed to deliver a non-invasive solution for diagnosing and managing coronary artery disease. The company operates and manages its business as a single reportable operating segment: non-invasive coronary artery disease detection solutions. Geographically, it operates in the United States and the rest of Europe, deriving the majority of its revenue from the United States. The company has developed three software products: Heartflow Roadmap Analysis, Heartflow FFRCT Analysis, and Heartflow Plaque Analysis.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 6.01 | |||||
Equity-to-Asset | 0.83 | |||||
Debt-to-Equity | 0.09 | |||||
Debt-to-EBITDA | -0.28 | |||||
Piotroski F-Score | N/A/9 | |||||
Altman Z-Score | 26.58 | |||||
Beneish M-Score | -0.48 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Future 3-5Y Total Revenue Growth Rate Estimate | 24.77 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 65.27 | |||||
9-Day RSI | 67.22 | |||||
14-Day RSI | 64.4 | |||||
3-1 Month Momentum % | 27.33 | |||||
6-1 Month Momentum % | 6.28 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 5.57 | |||||
Quick Ratio | 5.57 | |||||
Cash Ratio | 4.16 | |||||
Days Sales Outstanding | 57.48 | |||||
Days Payable | 25.44 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Shareholder Yield % | 3.65 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 78.06 | |||||
Operating Margin % | -35.83 | |||||
Net Margin % | -58.42 | |||||
EBITDA Margin % | -49.8 | |||||
FCF Margin % | -40.11 | |||||
OCF Margin % | -37.07 | |||||
ROA % | -39.61 | |||||
ROIC % | -75.64 | |||||
ROC (Joel Greenblatt) % | -294.91 | |||||
ROCE % | -41.82 | |||||
Moat Score | 5 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 11.01 | |||||
PB Ratio | 8.84 | |||||
Price-to-Tangible-Book | 8.84 | |||||
EV-to-EBIT | -23.56 | |||||
EV-to-EBITDA | -25.16 | |||||
EV-to-Revenue | 12.53 | |||||
EV-to-Forward-Revenue | 12.51 | |||||
EV-to-FCF | -31.24 | |||||
| Price-to-Net-Current-Asset-Value | 16.48 | |||||
| Price-to-Net-Cash | 25.29 | |||||
Earnings Yield (Greenblatt) % | -4.24 | |||||
FCF Yield % | -3.03 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:HTFL
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
HeartFlow Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 191.417 | ||
| EPS (TTM) ($) | -1.764 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | 64.4 | ||
| 14-Day ATR ($) | 1.96569 | ||
| 20-Day SMA ($) | 31.842 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range ($) | 20.13 - 41.2231 | ||
| Shares Outstanding (Mil) | 86.24 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
HeartFlow Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
HeartFlow Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-11-12 16:30 | In 135 days | ||
| Third quarter earnings results for 2026 | 2026-11-12 | In 134 days | ||
| Second quarter earnings results for 2026 | 2026-09-18 | In 79 days | ||
| General meeting for 2026 | 2026-06-16 08:00 | 32.82 (-1.47%) | ||
| First quarter earnings conference call for 2026 | 2026-05-14 16:30 | 31.20 (+4.98%) | ||
| First quarter earnings results for 2026 | 2026-05-14 | 31.20 (+4.98%) | ||
| Fourth quarter earnings conference call for 2025 | 2026-03-18 16:30 | 22.52 (+5.83%) | ||
| Annual report for 2025 | 2026-03-18 | 22.52 (+5.83%) | ||
| Fourth quarter earnings results for 2025 | 2026-03-18 | 22.52 (+5.83%) | ||
| Morgan Stanley Technology, Media & Telecom Conference | 2026-03-03 13:45 | 24.05 (+6.75%) |
Show
Entries
HeartFlow Inc Frequently Asked Questions
What is HeartFlow Inc(HTFL)'s stock price today?
The current price of HTFL is $29.33. The 52 week high of HTFL is $41.22 and 52 week low is $20.13.
When is next earnings date of HeartFlow Inc(HTFL)?
The next earnings date of HeartFlow Inc(HTFL) is 2026-09-18 Est..
Does HeartFlow Inc(HTFL) pay dividends? If so, how much?
HeartFlow Inc(HTFL) does not pay dividend.
Guru Commentaries on NAS:HTFL
No articles.
Press Release
| Subject | Date | ||
|---|---|---|---|
| 16 Million People, One Underserved Disease: The AI Imaging Push to Close the Congenital Heart Gap | 2026-06-16 |
Articles on HeartFlow Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers